Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · North Carolina

Biogen Drug Product

Durham, NC · ~215 workers · 3 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
0.3
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Biogen Drug Product runs at 11% of its industry's injury rate - far safer than the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade A.

Biogen Drug Product: 0.3 TCR = 11% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 3y Form 300A (see methodology below)

Biogen Drug Product safety composite

Biogen Drug Product scores strongest on total case rate (tcr) (safer than 92% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

B

78/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
A 0.35 per 100 workers

Safer than 92% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Biogen Drug Product held a steady TCR band

Biogen Drug Product's TCR held near 0.0 from 0.0 in 2018 to 0.0 in 2020. Peak filing year was 2019 at 1.0 TCR. In 2020, DART was 0× this establishment's average TCR (severity share of cases).

2018=0.0 · 2019=1.0 · 2020=0.0

OSHA ITA Form 300A scorecard

Establishment book 325412 · Durham, NC AT/BELOW-IND · MID

Grade A · TCR 0.3 · 11% of ind

  • DART 0.0 DART
  • RANK #8/47
  • PHOTO Cytovance Biologics
  • BOOK 3y book
  • INJ 2 inj
  • SIZE ~215 FTE

Nearest TCR peer: Cytovance Biologics (0.0 TCR gap)

Read with this employer → · Industry book → · North Carolina employers → · Look up another →

Biogen Drug Product in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Biogen Drug Product averages 0.3 TCR (11% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Biogen Drug Product TCR series: 2018=0 · 2019=1 · 2020=0 · BLS 3.3

Where Biogen Drug Product falls in its industry

855 Pharmaceutical preparations (e establishments

Safer than 92% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to North Carolina alone (the establishments it most directly competes with for workers and contracts): ranked #8 safest of 47 Pharmaceutical preparations (e employers in North Carolina.

Biogen Drug Product (215 employees, TCR 0.3) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate Biogen Drug Product
Biogen Drug Product (215 employees, TCR 0.3) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

Biogen Drug Product has more employees than the Pharmaceutical preparations (e.g., capsu median and a lower injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2020 0.0 0.0 0 0 0
2019 1.0 0.0 2 0 0
2018 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · NC · Durham

855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 16,981 rated employers in North Carolina with headcount on file · 530 employers in Durham, NC · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Cytovance Biologics 0.3 TCR
NAICS-TCR JANSSEN CILAG 0.3 TCR
NAICS-TCR Astellas Pharma US 0.3 TCR
NAICS-TCR AstraZeneca - Mt.Vernon 0.3 TCR
STATE-SIZE Bryant-Durham Electric Co., Inc. 215 FTE
STATE-SIZE Golding Farms Foods - Winston-Salem 215 FTE
STATE-SIZE Arden Companies - Sanford 215 FTE
STATE-SIZE 1180 - Greensboro Lawndale 215 FTE
CITY-NEAR Duke University 23,871 FTE
CITY-NEAR Duke University Hospital 11,048 FTE
CITY-NEAR BCBSNC Telecommuters 3,033 FTE
CITY-NEAR Wolfspeed - Durham, NC 3,013 FTE
NAT-TCR Dixie Chemical 0.3 TCR
NAT-TCR Williamsville CUSD #15 0.3 TCR
NAT-TCR LSI Technology 0.3 TCR
NAT-TCR Turner at Westlake Vinyls Company Geismar LA 0.3 TCR
NAT-SIZE Hart Components LLC 215 FTE
NAT-SIZE Victor Manufacturing 215 FTE
NAT-SIZE Digital Room LLC - Arlington Location 215 FTE
NAT-SIZE California Ofc/Whse 215 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2020, 2019, 2018. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.